Neurokinin A; Substance K; Neuromedin L; NKA CAS NO.86933-74-6

Neurokinin A; Substance K; Neuromedin L; NKA CAS NO.86933-74-6

Neurokinin A; Substance K; Neuromedin L; NKA CAS NO.86933-74-6

Neurokinin A; Substance K; Neuromedin L; NKA CAS NO.86933-74-6

Neurokinin A; Substance K; Neuromedin L; NKA CAS NO.86933-74-6

Neurokinin A (NKA), also known as Substance K or Neuromedin L, is an endogenous tachykinin decapeptide that serves as a key signaling molecule in neuroendocrine and inflammatory pathways. This research-grade synthetic peptide is supplied as a lyophilized powder with ≥95% HPLC purity, low endotoxin levels, and confirmed biological activity at neurokinin receptors. It is widely used as a standard agonist in receptor binding studies, functional assays, and pharmacological characterization of tachykinin signaling in respiratory, gastrointestinal, and cardiovascular systems.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Neurokinin A; Substance K; Neuromedin L; NKA
CAS NO.
86933-74-6
Appearance
White to off-white lyophilized powder
Molecular Formula
C50H80N14O14S
Molecular Weight
 1133.34g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, phosphate‑buffered saline (PBS), or dilute acetic acid (e.g., 0.1 % v/v). For best results, first dissolve in a small volume of 0.1 % acetic acid or sterile water to prepare a 0.1–1.0 mg/mL stock solution, then dilute with the desired assay buffer.

Endotoxin< 1.0 EU/mg
Biological Activity
Neurokinin A is an endogenous tachykinin peptide that acts as a high‑affinity agonist primarily at neurokinin‑2 receptors (NK₂R). It mediates smooth‑muscle contraction (especially in bronchial and gastrointestinal tracts), vasodilation, and neurogenic inflammation. Biological activity is typically confirmed in NK₂R‑expressing cell‑based assays (e.g., calcium mobilization, IP₃ accumulation) or isolated tissue contraction bioassays.
Storage Conditions
Lyophilized powder: Store desiccated at –20 °C or below, protected from light, for long‑term stability.
Reconstituted solution: Aliquot and store at ≤ –20 °C; avoid repeated freeze‑thaw cycles. For extended stability, store at –80 °C.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Neurokinin A acts primarily as a high-affinity agonist at neurokinin-2 receptors (NK₂R), binding to these G protein-coupled receptors to activate phospholipase C via Gq/11 coupling. This leads to increased production of inositol trisphosphate (IP₃) and diacylglycerol (DAG), resulting in calcium mobilization from intracellular stores. The subsequent signaling cascade mediates smooth muscle contraction in bronchial and gastrointestinal tissues, promotes neurogenic inflammation, and induces vasodilation. NKA also exhibits lower affinity for NK₁ and NK₃ receptors, contributing to its broad physiological effects in both central and peripheral nervous systems.


2.PRODUCT INDICATIONS

This Neurokinin A peptide is indicated exclusively for research use in preclinical studies of tachykinin receptor biology and neuroinflammatory pathways. It is employed as a standard agonist in receptor binding assays, calcium mobilization studies, and smooth muscle contraction bioassays to characterize NK₂R function in respiratory, gastrointestinal, and cardiovascular research. The product serves as a reference compound for screening NK₂R antagonists, studying neurogenic inflammation mechanisms, and investigating tachykinin signaling in disease models. It is not intended for diagnostic, therapeutic, or clinical applications in humans or animals.


3.CLINICAL EFFICACY OF PRODUCT

As a research reagent, Neurokinin A has no established clinical efficacy for therapeutic use in human patients. The product has not undergone clinical development, regulatory approval, or safety evaluation for any medical indication. While endogenous NKA plays important roles in asthma, irritable bowel syndrome, and inflammatory pain pathways, this synthetic peptide is solely an investigational tool for basic and translational research. Its utility is confined to laboratory applications, with no proven clinical benefits or safety profile in humans.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.